Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome Market

Acute Respiratory Distress Syndrome (ARDS) is a rapidly progressive disease that occurs in critically ill patients. ARDS's major complication is marked by leakage of fluid into the lungs, making breathing difficult or impossible. Acute lung injury (ALI) is a common condition characterized by acute severe hypoxia, which is not due to left atrial hypertension. The term ALI encompasses a continuum of clinical and radiographic changes, which affect the lungs, with the ARDS representing the more extreme end of this continuum. 


The causes of ARDS are divided into two categories: direct or indirect injuries to the lung. Some of the direct injuries to the lung are pneumonia, aspiration, trauma, and others. Simultaneously, the lung's indirect injuries are inflammation of the pancreas, severe infection (also known as sepsis), blood transfusions, burns, and medication reactions. 


Acute Respiratory Distress Syndrome Epidemiological Segmentation 

The Epidemiological Segmentation of Acute Respiratory Distress Syndrome in 7MM from 2017 to 2030 is segmented as:- 

  • Total Incident Population of Acute Respiratory Distress Syndrome
  • Severity-specific Incidence of Acute Respiratory Distress Syndrome
  • Incidence of Acute Respiratory Distress Syndrome by Risk Factors


Acute Respiratory Distress Syndrome Epidemiology 

  • The total incident population of Acute Respiratory Distress Syndrome in 7MM in 2017 was 7,99,872
  • The incidence of Acute Respiratory Distress Syndrome in the United States in 2017 was 4, 95,655  


Acute Respiratory Distress Syndrome Market

The market for Acute Respiratory Distress Syndrome in the 7MM is rising at a CAGR of 9.55% during the study period (2017–2030).


Acute Respiratory Distress Syndrome Emerging Drugs

The emerging drugs of the Acute Respiratory Distress Syndrome market are 

  • Traumakine
  • Bio-11006
  • MultiStem
  • Solnatide (AP301)
  • Ultomiris (ravulizumab-cwvz)
  • Soliris (eculizumab)

And many others.  


Acute Respiratory Distress Syndrome Key Players

The key players in the Acute Respiratory Distress Syndrome market are

  • Faron Pharmaceuticals
  • BioMarck Pharmaceuticals
  • Athersys
  • APEPTICO Forschung und Entwicklung GmbH
  • Alexion Pharma

And many others.